<DOC>
	<DOCNO>NCT01609738</DOCNO>
	<brief_summary>Cardiac pace effective treatment symptomatic bradycardia . The right ventricular apex ( RVA ) become frequently use ventricular pace site . However , RVA pace show cause leave ventricular ( LV ) dyssynchrony wich lead LV dysfunction development heart failure . Recent study animal demonstrate pace LV septum induces significantly less ventricular dyssynchrony RVA pacing able improve LV function similar degree biventricular ( BiV ) pacing . In addition show LV septum lead place permanently drive lead extend helix RV side inter-ventricular septum LV endocardial layer . This show feasible safe procedure lead stability show four month follow-up otherwise healthy active canine . LV septum pace may therefore good treatment alternative patient symptomatic bradycardia , well patient indication cardiac resynchronization therapy ( CRT ) . The purpose study translate finding preclinical study clinical situation investigate feasibility , long-term lead stability safety LV septum pace transvenous approach inter-ventricular septum patient .</brief_summary>
	<brief_title>Left Ventricular Septum Pacing Patients Transvenous Approach Through Inter-ventricular Septum</brief_title>
	<detailed_description>Cardiac pace effective treatment symptomatic bradycardia . After introduction implantable pacemaker ( PM ) , right ventricular apex ( RVA ) become frequently use ventricular pace site . However , clinical study show RVA pace lead leave ventricular ( LV ) dyssynchrony , long run adverse structural change ( remodel ) , high risk develop atrial fibrillation heart failure , high mortality . Recognition adverse effect RVA pace generate interest alternative ventricular pacing site . Recent study animal show pace LV septum induces significantly less ventricular dyssynchrony RVA pacing . In addition show LV septum lead place permanently introduce custom lead extend helix transvenously , position RV septum , drive inter-ventricular septum LV endocardial layer . This show feasible safe procedure lead stability show four month follow-up otherwise healthy active canine . Animal study also show LV septum pace able improve LV function similar degree simultaneous biventricular ( BiV ) pace use cardiac resynchronization therapy ( CRT ) . CRT introduce restore abnormal ventricular activation contraction patient heart failure intra-ventricular conduction delay . Large clinical trial show CRT improve LV systolic pump function , reverse structural remodelling , improve quality life exercise tolerance , decrease mortality . Unfortunately , problem encounter position fixation LV pace lead coronary vein result suboptimal loss CRT least quarter CRT candidate require re-operation 7 % follow . The adverse effect RVA pacing , limitation BiV pace promising effect LV septum pace preclinical study lead idea LV septum pacing may good treatment alternative patient symptomatic bradycardia , well patient indication CRT . In latter category , CRT could perform use single ventricular pace lead , thus limit number lead implantation , thereby reduce complication rate implantation cost well avoid difficult access route coronary vein . It aim study translate finding preclinical study clinical situation investigate feasibility , long-term lead stability safety LV septum pace transvenous approach inter-ventricular septum patient PM CRT indication . The result may large impact future pace therapy . The LV septum may become universal pace site , preferred anti-bradycardia therapy , equal alternative BiV pacing , easy apply , less invasive cost-effective .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>1 . Cardiac pace indication sinus node dysfunction ( dual chamber pacemaker ) indication CRT ( BiV pacemaker ) . Patient sinus node dysfunction : Normal leave ventricular ejection fraction ( LVEF &gt; 50 % ) Left ventricular enddiastolic diameter ( LVEDD ) &lt; 55mm QRS duration &lt; 100ms Patient CRT indication : Nonischemic cardiomyopathy LVEF &lt; 35 % Typical leave bundlebranch block surface ECG QRS duration &gt; 150ms NYHA functional class IIII 2 . Greater 18 year age 3 . Stable sinus rhythm time inclusion 4 . Willing capable give informed consent 1 . Ventricular pace dependent 2 . High degree AV block 3 . Previous septal myocardial infarction 4 . Previously implant pacing device 5 . Abnormal venous anatomy 6 . Left ventricular septum wall thickness &gt; 10mm determine echocardiography 7 . Presence severe valvular disease 8 . Presence ongoing progressive terminal disease associate reduce likelihood survival duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Cardiac pacing</keyword>
	<keyword>Left ventricular septal pacing</keyword>
	<keyword>Feasibility safety</keyword>
	<keyword>Lead stability</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Left ventricular dyssynchrony</keyword>
	<keyword>Pacing heart failure</keyword>
	<keyword>Cardiac resynchronization therapy</keyword>
</DOC>